The role of proliferator-activated receptor γ coactivator-1α in the fatty-acid-dependent transcriptional control of interleukin-10 in hepatic cells of rodents

Metabolism: Clinical and Experimental

Volumn 59, Issue 2, 2010, Pages 215-223

  Morari, Joseane ^a   Torsoni, Adriana S ^a   Anhê, Gabriel F ^b   Roman, Erika A ^a   Cintra, Dennys E ^a   Ward, Laura S ^a   Bordin, Silvana ^b   Velloso, Lício A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR C MAF;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATTY ACID METABOLISM; IMMUNOMODULATION; INFLAMMATION; INSULIN RESISTANCE; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; STEATOSIS; TRANSCRIPTION REGULATION;

ANIMALS; CELL NUCLEUS; DNA; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEPATOCYTES; INTERLEUKIN-10; MALE; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MAF; RATS; RATS, WISTAR; RNA-BINDING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 74049092099     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.020     Document Type: Article

References (31)

1. Yeh M.M., and Brunt E.M. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 128 (2007) 837-847
2. Medina J., Fernandez-Salazar L.I., Garcia-Buey L., and Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27 (2004) 2057-2066
3. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
4. Delgado J.S. Evolving trends in nonalcoholic fatty liver disease. Eur J Intern Med 19 (2008) 75-82
5. Hashem R.M., Mahmoud M.F., El-Moselhy M.A., and Soliman H.M. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis. Eur J Gastroenterol Hepatol 20 (2008) 995-1001
6. Cintra D.E., Pauli J.R., Araujo E.P., Moraes J.C., de Souza C.T., Milanski M., Morari J., et al. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 48 (2008) 628-637
7. den Boer M.A., Voshol P.J., Schroder-van der Elst J.P., Korsheninnikova E., Ouwens D.M., Kuipers F., Havekes L.M., et al. Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice. Endocrinology 147 (2006) 4553-4558
8. Zhang L.J., and Wang X.Z. Interleukin-10 and chronic liver disease. World J Gastroenterol 12 (2006) 1681-1685
9. Handschin C., and Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27 (2006) 728-735
10. De Souza C.T., Araujo E.P., Prada P.O., Saad M.J., Boschero A.C., and Velloso L.A. Short-term inhibition of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression reverses diet-induced diabetes mellitus and hepatic steatosis in mice. Diabetologia 48 (2005) 1860-1871
11. Cao S., Liu J., Song L., and Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol 174 (2005) 3484-3492
12. Lee K.G., Xu S., Wong E.T., Tergaonkar V., and Lam K.P. Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells. J Biol Chem 283 (2008) 11189-11198
13. Wang L.H., Yang X.Y., Zhang X., and Farrar W.L. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. Blood 110 (2007) 4373-4384
14. Homma Y., Cao S., Shi X., and Ma X. The Th2 transcription factor c-Maf inhibits IL-12p35 gene expression in activated macrophages by targeting NF-kappaB nuclear translocation. J Interferon Cytokine Res 27 (2007) 799-808
15. Cao S., Liu J., Chesi M., Bergsagel P.L., Ho I.C., Donnelly R.P., et al. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J Immunol 169 (2002) 5715-5725
16. Koch T.R., and Nipper H.C. Evaluation of automated glucose oxidase methods for serum glucose: comparison to hexokinase of a colorimetric and an electrometric method. Clin Chim Acta 78 (1977) 315-322
17. McGowan M.W., Artiss J.D., Strandbergh D.R., and Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29 (1983) 538-542
18. Lidofsky S.D., Hinsberg III W.D., and Zare R.N. Enzyme-linked sandwich immunoassay for insulin using laser fluorimetric detection. Proc Natl Acad Sci U S A 78 (1981) 1901-1905
19. Lin X.Z., Horng M.H., Sun Y.N., Shiesh S.C., Chow N.H., and Guo X.Z. Computer morphometry for quantitative measurement of liver fibrosis: comparison with Knodell's score, colorimetry and conventional description reports. J Gastroenterol Hepatol 13 (1998) 75-80
20. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
21. Araujo E.P., De Souza C.T., Ueno M., Cintra D.E., Bertolo M.B., Carvalheira J.B., Saad M.J., et al. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 148 (2007) 5991-5997
22. Wang S.C., Ohata M., Schrum L., Rippe R.A., and Tsukamoto H. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273 (1998) 302-308
23. Wahl C., Bochtler P., Schirmbeck R., and Reimann J. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes. J Immunol 178 (2007) 2083-2093
24. Knolle P., Schlaak J., Uhrig A., Kempf P., Meyer zum Buschenfelde K.H., and Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 22 (1995) 226-229
25. Elinav E., Pappo O., Sklair-Levy M., Margalit M., Shibolet O., Gomori M., Alper R., et al. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. J Pathol 208 (2006) 74-81
26. Lin S.C. Identification of an NF-Y/HMG-I(Y)-binding site in the human IL-10 promoter. Mol Immunol 43 (2006) 1325-1331
27. Barbuio R., Milanski M., Bertolo M.B., Saad M.J., and Velloso L.A. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 194 (2007) 539-550
28. Nishitani Y., Okazaki S., Imabayashi K., Katada R., Umetani K., Yajima H., et al. Saturated and monounsaturated fatty acids increase interleukin-10 production in rat hepatocytes. Nihon Arukoru Yakubutsu Igakkai Zasshi 42 (2007) 32-35
29. Cao S., Zhang X., Edwards J.P., and Mosser D.M. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 281 (2006) 26041-26050
30. Choi C.S., Befroy D.E., Codella R., Kim S., Reznick R.M., Hwang Y.J., Liu Z.X., et al. Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Natl Acad Sci U S A 105 (2008) 19926-19931
31. Erion D.M., Yonemitsu S., Nie Y., Nagai Y., Gillum M.P., Hsiao J.J., Iwasaki T., et al. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc Natl Acad Sci U S A 106 (2009) 11288-11293